Industrial endocrine disruptors and polycystic ovary syndrome (Q34399051)

1 August 2017

Industrial endocrine disruptors and polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

1 August 2017

1 reference

1 reference

1 reference

Evanthia Diamanti-Kandarakis

series ordinal

2

object named as

E Diamanti-Kandarakis

1 reference

1 August 2017

E Palioura

1

1 reference

PubMed ID

24445124

1 August 2017

language of work or name

1 reference

1 December 2013

1 reference

Journal of Endocrinological Investigation

1 August 2017

1 reference

1 August 2017

36

1 reference

1 August 2017

11

1 reference

1 August 2017

1105-1111

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03346762

1 August 2017

0 references

cites work

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Phenotypes and enviromental factors: their influence in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Endocrine-disrupting chemicals: an Endocrine Society scientific statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Bisphenol A impairs follicle growth, inhibits steroidogenesis, and downregulates rate-limiting enzymes in the estradiol biosynthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Bisphenol A concentration-dependently increases human granulosa-lutein cell matrix metalloproteinase-9 (MMP-9) enzyme output

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

MMPS and TIMPS in ovarian physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Follicular dynamics in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Follicle dynamics and anovulation in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Longterm management of Polycystic Ovarian Syndrome (PCOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Chemical toxins: a hypothesis to explain the global obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Association of endocrine disruptors and obesity: perspectives from epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Perinatal exposure to bisphenol a alters early adipogenesis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Impact of endocrine-disrupting compounds (EDCs) on female reproductive health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Intra-follicular activin availability is altered in prenatally-androgenized lambs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346762

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

12 December 2020

Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome

1 reference

12 December 2020

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.

1 reference

12 December 2020

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

1 reference

12 December 2020

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346762

1 reference

PubMed ID

24445124

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

24445124